DI BELLA METHOD
>
DOCUMENTATION INDEX > SCIENTIFIC WORKS
Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells.
(13/04/2011)
Detail
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
(13/04/2011)
Detail
The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats.
(13/04/2011)
Detail
The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats.
(13/04/2011)
Detail
The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats.
(13/04/2011)
Detail
The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats.
(13/04/2011)
Detail
Retinoids regulate stem cell differentiation.
(13/04/2011)
Detail
Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies.
(13/04/2011)
Detail
Retinal and retinol are potential regulators of gene expression in the keratinocyte cell line HaCaT.
(13/04/2011)
Detail
Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.
(13/04/2011)
Detail
Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.
(13/04/2011)
Detail
Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas.
(13/04/2011)
Detail
All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules.
(13/04/2011)
Detail
All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules.
(13/04/2011)
Detail
Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines.
(13/04/2011)
Detail